Ultimovacs ASA: Third quarter 2021 result presentation
Oslo, 11November 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces its third quarter 2021 results today. The presentation by the company’s management team will take place at Oslo…
